WASHINGTON (Legal Newsline) — The U.S. Supreme Court on Thursday ruled mostly against a Utah-based molecular diagnostic company in its attempt to patent a pair of genes linked to breast and ovarian cancer.
In its unanimous opinion, the nation’s high court wrote that defendant Myriad Genetics Inc. “did not create anything.”
“To be sure, it found an important and useful gene, but separating that gene from its surrounding genetic material is not an act of invention,” Justice Clarence Thomas wrote in the court’s 18-page ruling.
Read the rest of the story on Legal Newsline ...